Bacteriocins of lactic acid bacteria: extending the family P Alvarez-Sieiro, M Montalbán-López, D Mu, OP Kuipers Applied microbiology and biotechnology 100 (7), 2939-2951, 2016 | 837 | 2016 |
Bacteriocins of lactic acid bacteria: extending the family P Alvarez-Sieiro, M Montalbán-López, D Mu, OP Kuipers Applied microbiology and biotechnology 100 (7), 2939-2951, 2016 | 837 | 2016 |
New developments in RiPP discovery, enzymology and engineering M Montalbán-López, TA Scott, S Ramesh, IR Rahman, AJ van Heel, ... Natural Product Reports 38 (1), 130-239, 2021 | 617 | 2021 |
BAGEL3: automated identification of genes encoding bacteriocins and (non-) bactericidal posttranslationally modified peptides AJ van Heel, A de Jong, M Montalbán-López, J Kok, OP Kuipers Nucleic Acids Research 41, W448-453, 2013 | 561 | 2013 |
Genetic features of circular bacteriocins produced by Gram-positive bacteria MMB Mercedes Maqueda, Marina Sánchez‐Hidalgo, Matilde Fernández, Manuel ... FEMS Microbiol Rev 32, 2-22, 2008 | 232 | 2008 |
Genetic features of circular bacteriocins produced by Gram‐positive bacteria M Maqueda, M Sánchez‐Hidalgo, M Fernández, M Montalbán‐López, ... FEMS microbiology reviews 32 (1), 2-22, 2008 | 232 | 2008 |
Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens Q Li, M Montalban-Lopez, OP Kuipers Applied and Environmental Microbiology 84 (12), e00052-18, 2018 | 170 | 2018 |
Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans AJ van Heel, M Montalban-Lopez, OP Kuipers Expert Opinion on Drug Metabolism & Toxicology 7 (6), 675-680, 2011 | 161 | 2011 |
AS-48 bacteriocin: close to perfection M Sánchez-Hidalgo, M Montalbán-López, R Cebrián, E Valdivia, ... Cellular and Molecular Life Sciences 68 (17), 2845-2857, 2011 | 127 | 2011 |
Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale S Schmitt, M Montalbán-López, D Peterhoff, J Deng, R Wagner, M Held, ... Nature chemical biology 15 (5), 437-443, 2019 | 116 | 2019 |
Are bacteriocins underexploited? Novel applications for old antimicrobials M Montalbán-López, M Sánchez-Hidalgo, E Valdivia, M Martínez-Bueno, ... Current pharmaceutical biotechnology 12 (8), 1205-1220, 2011 | 115 | 2011 |
Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes AJ van Heel, D Mu, M Montalbán-López, D Hendriks, OP Kuipers ACS synthetic biology 2 (7), 397-404, 2013 | 111 | 2013 |
Designing and Producing Modified, New-to-Nature Peptides with Antimicrobial Activity by Use of a Combination of Various Lantibiotic Modification Enzymes AJ van Heel, D Mu, M Montalbán-López, D Hendriks, OP Kuipers ACS synthetic biology 2 (7), 397-404, 2013 | 111 | 2013 |
Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery AJ van Heel, TG Kloosterman, M Montalban-Lopez, J Deng, A Plat, ... ACS synthetic biology 5 (10), 1146-1154, 2016 | 102 | 2016 |
Potentiating the activity of nisin against Escherichia coli L Zhou, AJ van Heel, M Montalban-Lopez, OP Kuipers Frontiers in cell and developmental biology 4, 7, 2016 | 93 | 2016 |
Size control of in vitro synthesized magnetite crystals by the MamC protein of Magnetococcus marinus strain MC-1 C Valverde-Tercedor, M Montalbán-López, T Perez-Gonzalez, ... Applied microbiology and biotechnology 99 (12), 5109-5121, 2015 | 92 | 2015 |
NisC binds the FxLx motif of the nisin leader peptide A Abts, M Montalban-Lopez, OP Kuipers, SH Smits, L Schmitt Biochemistry 52 (32), 5387-5395, 2013 | 75 | 2013 |
Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials M Montalbán-López, AJ van Heel, OP Kuipers FEMS microbiology reviews 41 (1), 5-18, 2017 | 72 | 2017 |
Discovering the bacterial circular proteins: bacteriocins, cyanobactins, and pilins M Montalbán-López, M Sánchez-Hidalgo, R Cebrián, M Maqueda Journal of Biological Chemistry 287 (32), 27007-27013, 2012 | 67 | 2012 |
Outer-membrane-acting peptides and lipid II-targeting antibiotics cooperatively kill Gram-negative pathogens Q Li, R Cebrián, M Montalbán-López, H Ren, W Wu, OP Kuipers Communications biology 4 (1), 1-11, 2021 | 66 | 2021 |